Nanoliposomal irinotecan plus fluorouracil and folinic acid in irinotecan-pretreated vs. -naive pancreatic cancer patients: A retrospective cohort study

被引：0
|
作者：
Schoenlein, M. [1 ]
Stein, A. [1 ,2 ]
Tintelnot, J. [1 ]
Nilsson, S. [1 ]
Reichelt, R. [3 ]
Borchardt, J. [3 ]
Schnell, R. [4 ]
Goekkurt, E. [1 ,2 ]
Bokemeyer, C. [1 ]
Sinn, M. [1 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Med Klin & Poliklin Onkol Hamatol & Knochenmarktr, Abt Pneumol, Hamburg, Germany
[2] Hematol Oncol Practice Hamburg HOPE, Hamburg, Germany
[3] Onkotrakt AG, Hamburg, Germany
[4] Pioh Koln Nord Studien GbR, Cologne, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ep601
引用
收藏
页码：224 / 225
页数：2
相关论文
共 50 条
  • [21] A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX)
    Atkins, Katelyn Mae
    Gong, Jun
    Tighiouart, Mourad
    Klempner, Samuel J.
    Tuli, Richard
    Placencio-Hickok, Veronica
    Hendifar, Andrew Eugene
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [22] A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX).
    Hendifar, Andrew Eugene
    Kim, Sungjin
    Tighiouart, Mourad
    Hautamaki, Emily
    Kim, Haesoo
    Ng, Camille
    Liu, Jar-Yee
    Scher, Kevin S.
    Klempner, Samuel J.
    Placencio-Hickok, Veronica
    Gresham, Gillian
    Gong, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] First evidence for the antitumor activity of nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic biliary tract cancer
    Hossein Taghizadeh
    Matthias Unseld
    Andreas Schmiderer
    Angela Djanani
    Klaus Wilthoner
    Dieter Buchinger
    Gerald W. Prager
    Cancer Chemotherapy and Pharmacology, 2020, 86 : 109 - 115
  • [24] Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer
    Yalcin, S
    Oksuzoglu, B
    Tekuzman, G
    Engin, H
    Celik, I
    Turker, A
    Barista, I
    Gullu, I
    Guler, N
    Altundag, K
    Ozisik, Y
    Kars, A
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (11) : 580 - 583
  • [25] A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients
    C Garufi
    E Bria
    B Vanni
    A M R Zappalà
    I Sperduti
    E Terzoli
    British Journal of Cancer, 2003, 89 : 1870 - 1875
  • [26] A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients
    Garufi, C
    Bria, E
    Vanni, B
    Zappalà, AMR
    Sperduti, I
    Terzoli, E
    BRITISH JOURNAL OF CANCER, 2003, 89 (10) : 1870 - 1875
  • [27] First evidence for the antitumor activity of nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic biliary tract cancer
    Taghizadeh, Hossein
    Unseld, Matthias
    Schmiderer, Andreas
    Djanani, Angela
    Wilthoner, Klaus
    Buchinger, Dieter
    Prager, Gerald W.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (01) : 109 - 115
  • [28] Nanoliposomal irinotecan plus 5-fluorouracil, leucovorin as post-gemcitabine-based therapy in pancreatic cancer
    Mori, Chinatsu
    Ozaka, Masato
    Mie, Takafumi
    Furukawa, Takaaki
    Yamada, Yuto
    Okamoto, Takeshi
    Takeda, Tsuyoshi
    Kasuga, Akiyoshi
    Matsuyama, Masato
    Sasaki, Takashi
    Sasahira, Naoki
    ANNALS OF ONCOLOGY, 2022, 33 : S543 - S543
  • [29] Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study
    Nagashima, Shuhei
    Kobayashi, Satoshi
    Tsunoda, Shotaro
    Yamachika, Yui
    Tozuka, Yuichiro
    Fukushima, Taito
    Morimoto, Manabu
    Ueno, Makoto
    Furuse, Junji
    Maeda, Shin
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (02) : 188 - 194
  • [30] Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study
    Shuhei Nagashima
    Satoshi Kobayashi
    Shotaro Tsunoda
    Yui Yamachika
    Yuichiro Tozuka
    Taito Fukushima
    Manabu Morimoto
    Makoto Ueno
    Junji Furuse
    Shin Maeda
    International Journal of Clinical Oncology, 2024, 29 : 188 - 194
12345